Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Margaretha Olthoff has worked on the following 4 EPO patent applications which have been published in the last five years:

EP11727396

ORAL DOSAGE FORMS OF BENDAMUSTINE

IPC classification:
A61K 9/14, A61K 9/48, A61K 31/4184, A61K 47/10
Agent:
Margaretha Olthoff, Astellas Pharma Europe BV
Status:
EXAMINATION IN PROGRESS
EP11727917

ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/4184, A61K 47/10
Agent:
Margaretha Olthoff, Astellas Pharma Europe BV
Status:
EXAMINATION IN PROGRESS
EP14701907

COMPOSITION OF TIACUMICIN COMPOUNDS

IPC classification:
A61K 9/00, A61K 9/16, A61K 47/36, A61K 47/38
Agent:
Margaretha Olthoff, Astellas Pharma Europe BV
Status:
GRANT OF PATENT INTENDED
EP16075001

SYSTEM AND METHOD FOR ANALYZING ADVERSE EVENT DATA

IPC classification:
G06F 19/00
Agent:
Margaretha Olthoff, Astellas Pharma Europe BV
Status:
Request for examination was made

Please Sign in to use this feature